[Skip to Content]
[Skip to Content Landing]
March 12, 1960


JAMA. 1960;172(11):1165-1166. doi:10.1001/jama.1960.03020110049013

The cervix is the second commonest site for cancer in women in the United States; in women of some other countries it is the commonest site. However, if treated adequately, cancer of the cervix has the best prognosis of all major forms of malignancy. The most important single factor influencing prognosis is the extent of the disease. The combination of cytological study of vaginal fluid and biopsy of the cervix results in a nearly perfect diagnostic score. This procedure could reduce significantly cancer of the cervix as a cause of death, if it were applied regularly to all women, or at least to all past 35 years of age.1 The experience of the Strang Cancer Prevention Clinic at Memorial Hospital in New York City, together with studies being completed on 108,000 women in Memphis, Tenn., under the auspices of the United States Public Health Service, substantiates this assumption. The screening

First Page Preview View Large
First page PDF preview
First page PDF preview